Cargando…
Effects of an Adenosine A(2A) Receptor Antagonist on Striatal Dopamine D2-Type Receptor Availability: A Randomized Control Study Using Positron Emission Tomography
Introduction: Altered dopaminergic neurotransmission, especially in the functioning of dopamine D2-type receptors, is considered central to the etiology of a variety of neuropsychiatric disorders. In particular, individuals with substance use disorders have been consistently observed to exhibit lowe...
Autores principales: | Okita, Kyoji, Kato, Koichi, Shigemoto, Yoko, Sato, Noriko, Matsumoto, Toshihiko, Matsuda, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475186/ https://www.ncbi.nlm.nih.gov/pubmed/34588952 http://dx.doi.org/10.3389/fnins.2021.729153 |
Ejemplares similares
-
Potential Treat-to-Target Approach for Methamphetamine Use Disorder: A Pilot Study of Adenosine 2A Receptor Antagonist With Positron Emission Tomography
por: Okita, Kyoji, et al.
Publicado: (2022) -
Cigarette Use and Striatal Dopamine D2/3 Receptors: Possible Role in the Link between Smoking and Nicotine Dependence
por: Okita, Kyoji, et al.
Publicado: (2016) -
Striatal Dopamine D1-type Receptor Availability: No Difference from Control but Association with Cortical Thickness in Methamphetamine Users
por: Okita, Kyoji, et al.
Publicado: (2017) -
Striatal Pre- and Postsynaptic Profile of Adenosine A(2A) Receptor Antagonists
por: Orru, Marco, et al.
Publicado: (2011) -
Decreased striatal adenosine A(2A)-dopamine D(2) receptor heteromerization in schizophrenia
por: Valle-León, Marta, et al.
Publicado: (2020)